In a different study, Alafate et al., have performed kinome analysis and identified that AURKB is an important candidate responsible for the chemoresistance in temozolomide-resistant glioblastoma cells and the associated drug resistance could be mitigated by combined targeting of AURKB along with temozolomide [175]. The gene discussed is AURKB; the disease is glioblastoma.